HomeMCPWorkbenchSkills
HomeWorkbenchNotificationsMe
llms.txt · MCP GuidePrivacy Policy · Terms of Service · Supportv1.8.3
  1. Home
  2. /Reaction

Lithium Bromide → 2-[[(5S)-2-oxo-3-[4-(3-oxomorpholin-4-yl)phenyl]-1,3-oxazolidin-5-yl]methyl]isoindole-1,3-dione

HRID 1523706
Print

Reaction equation

HRID 1523706 reaction equation
[O:1]1[CH2:3][C@@H:2]1[CH2:4][N:5]1[C:13](=[O:14])[C:12]2[C:7](=[CH:8][CH:9]=[CH:10][CH:11]=2)[C:6]1=[O:15].[N:16]([C:19]1[CH:24]=[CH:23][C:22]([N:25]2[CH2:30][CH2:29][O:28][CH2:27][C:26]2=[O:31])=[CH:21][CH:20]=1)=[C:17]=[O:18].[Br-].[Li+]>CC1C=CC(C)=CC=1.CC1C=CC=C(C)C=1.CC1C(C)=CC=CC=1>[O:18]=[C:17]1[N:16]([C:19]2[CH:24]=[CH:23][C:22]([N:25]3[CH2:30][CH2:29][O:28][CH2:27][C:26]3=[O:31])=[CH:21][CH:20]=2)[CH2:3][C@H:2]([CH2:4][N:5]2[C:13](=[O:14])[C:12]3[C:7](=[CH:8][CH:9]=[CH:10][CH:11]=3)[C:6]2=[O:15])[O:1]1
ParticipantsConditionsProcedureWorkupSources & evidenceReaction notes

Participants

5

Reactant 3

HCID 82050Lithium BromideHCID 719412(S)-(+)-N-(2,3-Epoxypropyl)phthalimideHCID 533414214-(4-Isocyanatophenyl)morpholin-3-one

Product 1

HCID 116903172-[[(5S)-2-oxo-3-[4-(3-oxomorpholin-4-yl)phenyl]-1,3-oxazolidin-5-yl]methyl]isoindole-1,3-dioneYield 94.64%

Reagents, catalysts & solvents 1

HCID 6850715
1,2-Xylene; 1,3-xylene; 1,4-xylene
Solvent

Conditions

Temperature
125 °C

Procedure

(S)-2-(oxiran-2-ylmethyl)isoindoline-1,3-dione (3.87 g, 19.06 mmol, 1.1 eq.) and 4-(4-isocyanatophenyl)morpholin-3-one (3.77 g, 17.29 mmol) were dissolved in xylenen (70 mL) respectively and heated to 125° C. Then lithium bromide (0.15 g, 1.74 mmol) was added, the mixture was reacted for 4 h, white solid was obtained by filtration (6.89 g, yield: 94.64%).

Workup

  1. customthe mixture was reacted for 4 h
  2. customwhite solid was obtained by filtration (6.89 g, yield: 94.64%)

Sources & evidence

ORD record
ord-0eefe3d8b32f4426801c68b71c1f3624
Source dataset
uspto-grants-2015_07
DOI
10.6084/m9.figshare.5104873.v1
Patent number
US09079892B2

Reaction notes

On this pageParticipantsConditionsProcedureWorkupSources & evidenceReaction notes